CFSB Bancorp
CFSB
CFSB was delisted on the 31st of October, 2025.
10 hedge funds and large institutions have $595K invested in CFSB Bancorp in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
35% more capital invested
Capital invested by funds: $441K → $595K (+$154K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 1.15% → 1.12% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$74.1K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$408 |
| 3 |
Wells Fargo
San Francisco,
California
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OC
Oppenheimer & Close
New York
|
-$77.7K |
| 2 |
BlackRock
New York
|
-$1.82K |
CFSB Hedge Fund Activity: Q2 2023 in Review
10 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in CFSB Bancorp (CFSB) for Q2 2023, worth a combined $595K — up 35% from $441K a quarter earlier.
Fund positioning in CFSB was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $74.1K. The largest seller was Oppenheimer & Close, exiting entirely with an estimated $77.7K sold.
- 10 institutional investors held CFSB Bancorp (CFSB) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $595K of CFSB Bancorp stock for Q2 2023, up 35% quarter-over-quarter.
- 2 funds opened new CFSB Bancorp positions in Q2 2023 and 2 closed out, a net change of 0 holders.
- The largest CFSB Bancorp buyer in Q2 2023 was Fidelity Investments, an estimated $74.1K added.
- The largest CFSB Bancorp seller in Q2 2023 was Oppenheimer & Close, an estimated $77.7K sold.
Based on aggregated 13F filings for Q2 2023.